Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Cancer Science: Mutations in the ALK Receptor Kinase cause Neuroblastoma
Sara Hartley, MDLinx Oncology
Technology Advances: Laser Microscopy Offers Vista of Real-Time Cell Movements
Dorothy J. Schirf, MD, MDLinx Oncology
OIG Compares ASP To AMP One More Time
Roberta Buell, MBA, Sausalito Healthcare Partners
  See all
follicular lymphoma; TP53 mutation and poorer overall survival Article Summary

Print     Email This Article     Save in My Library   Free Abstract
O'Shea D et al. - In a study to investigate the prognostic value of TP53 mutation at diagnosis in follicular lymphoma (FL), it was found that molecular features of the malignant cell may correlate with the nature of the immune response in FL

Methods
  • As TP53 mutations are associated with poor prognosis in hematological malignancies, the prognostic value of TP53 mutation was investigated in the diagnosis of FL

Results
  • Heterozygous TP53 mutation was detected in 12/185 analyzed cases
  • Mutation was associated with older age and higher IPI score
  • On multivariate analysis, TP53 mutation correlated with shorter progression-free and overall survival
  • TP53 mutation was associated with low expression of the immune-response 1 gene expression signature and with an unfavorable gene expression-based survival predictor score

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- LEUKEMIA/LYMPHOMA TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Bortezomib for initial therapy in multiple myeloma
National Cancer Institute, 09/18/08

PET scanning and prognosis in Hodgkins lymphoma
Current Opinion in Oncology, 09/02/08

Allogeneic transplantation for Hodgkin lymphoma
British Journal of Haematology, 09/05/08


Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.